Fulcrum Therapeutics, Inc.
← Back to FULC Overview

Fulcrum Therapeutics, Inc. (FULC)

Solvency & Capital Structure

Total Debt

$5.3M

Net Debt

-$313.6M

Fulcrum Therapeutics, Inc. currently has $5.3M in total debt. Net debt is -$313.6M after cash offsets. This 'Net Cash' position indicates exceptional financial strength.

Financial Fundamentals

FULCQuarterly Data • 5Y View

DateTotal Debt ($B)Cash & Inv. ($B)Net Debt ($B)Total AssetsDebt/Assets
2026-06-300.010.32-0.31Net Cash0.321.6%
2026-03-310.010.33-0.33Net Cash0.351.7%
2025-12-310.010.35-0.35Net Cash0.371.8%
2025-09-300.010.20-0.19Net Cash0.213.3%
2025-06-300.010.21-0.21Net Cash0.233.3%
2025-03-310.010.23-0.22Net Cash0.243.3%
2024-12-310.010.24-0.23Net Cash0.263.3%
2024-09-300.010.26-0.25Net Cash0.283.3%
2024-06-300.010.27-0.26Net Cash0.293.3%
2024-03-310.010.21-0.20Net Cash0.234.4%
2023-12-310.010.24-0.23Net Cash0.264.2%
2023-09-300.010.26-0.25Net Cash0.284.1%
2023-06-300.010.28-0.27Net Cash0.304.0%
2023-03-310.010.30-0.29Net Cash0.324.0%
2022-12-310.010.20-0.19Net Cash0.235.9%
2022-09-300.010.22-0.21Net Cash0.255.7%
2022-06-300.010.17-0.15Net Cash0.207.5%
2022-03-310.020.20-0.18Net Cash0.226.9%
2021-12-310.000.22-0.22Net Cash0.230.0%
2021-09-300.000.24-0.24Net Cash0.260.0%
2021-06-300.000.13-0.13Net Cash0.140.0%
2021-03-310.000.14-0.14Net Cash0.160.0%
2020-12-310.000.11-0.11Net Cash0.130.0%
2020-09-300.000.13-0.13Net Cash0.140.0%
2020-06-300.000.13-0.13Net Cash0.140.0%
2020-03-310.000.08-0.08Net Cash0.090.1%
2019-12-310.000.10-0.10Net Cash0.110.0%
2019-09-300.000.10-0.10Net Cash0.120.0%
2019-06-300.000.05-0.05Net Cash0.070.1%
2019-03-310.000.06-0.06Net Cash0.080.1%
2018-12-310.000.07-0.07Net Cash0.090.1%
2018-03-310.000.00-0.00Net Cash0.00